151 related articles for article (PubMed ID: 28155721)
1. Computer prediction of paratope on antithrombotic antibody 10B12 and epitope on platelet glycoprotein VI via molecular dynamics simulation.
Liu W; Liu G; Zhou H; Fang X; Fang Y; Wu J
Biomed Eng Online; 2016 Dec; 15(Suppl 2):152. PubMed ID: 28155721
[TBL] [Abstract][Full Text] [Related]
2. Mapping paratope on antithrombotic antibody 6B4 to epitope on platelet glycoprotein Ibalpha via molecular dynamic simulations.
Fang X; Fang Y; Liu L; Liu G; Wu J
PLoS One; 2012; 7(7):e42263. PubMed ID: 22860101
[TBL] [Abstract][Full Text] [Related]
3. Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody.
Smethurst PA; Joutsi-Korhonen L; O'Connor MN; Wilson E; Jennings NS; Garner SF; Zhang Y; Knight CG; Dafforn TR; Buckle A; IJsseldijk MJ; De Groot PG; Watkins NA; Farndale RW; Ouwehand WH
Blood; 2004 Feb; 103(3):903-11. PubMed ID: 14504096
[TBL] [Abstract][Full Text] [Related]
4. Gain- and loss-of-function mutants confirm the importance of apical residues to the primary interaction of human glycoprotein VI with collagen.
O'Connor MN; Smethurst PA; Farndale RW; Ouwehand WH
J Thromb Haemost; 2006 Apr; 4(4):869-73. PubMed ID: 16405521
[TBL] [Abstract][Full Text] [Related]
5. Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha.
Fontayne A; De Maeyer B; De Maeyer M; Yamashita M; Matsushita T; Deckmyn H
J Biol Chem; 2007 Aug; 282(32):23517-24. PubMed ID: 17569666
[TBL] [Abstract][Full Text] [Related]
6. Selective blockade of glycoprotein VI clustering on collagen helices.
O'Connor MN; Smethurst PA; Davies LW; Joutsi-Korhonen L; Onley DJ; Herr AB; Farndale RW; Ouwehand WH
J Biol Chem; 2006 Nov; 281(44):33505-10. PubMed ID: 16956881
[TBL] [Abstract][Full Text] [Related]
7. Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain.
Staelens S; Hadders MA; Vauterin S; Platteau C; De Maeyer M; Vanhoorelbeke K; Huizinga EG; Deckmyn H
J Biol Chem; 2006 Jan; 281(4):2225-31. PubMed ID: 16314412
[TBL] [Abstract][Full Text] [Related]
8. Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites.
Lecut C; Arocas V; Ulrichts H; Elbaz A; Villeval JL; Lacapère JJ; Deckmyn H; Jandrot-Perrus M
J Biol Chem; 2004 Dec; 279(50):52293-9. PubMed ID: 15466473
[TBL] [Abstract][Full Text] [Related]
9. Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library.
Kato-Takagaki K; Mizukoshi Y; Yoshizawa Y; Akazawa D; Torii Y; Ono K; Tanimura R; Shimada I; Takahashi H
J Biol Chem; 2009 Apr; 284(16):10720-7. PubMed ID: 19228693
[TBL] [Abstract][Full Text] [Related]
10. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
11. A new monoclonal antibody, mAb 204-11, that influences the binding of platelet GPVI to fibrous collagen.
Moroi M; Mizuguchi J; Kawashima S; Nagamatsu M; Miura Y; Nakagaki T; Ito K; Jung SM
Thromb Haemost; 2003 Jun; 89(6):996-1003. PubMed ID: 12783112
[TBL] [Abstract][Full Text] [Related]
12. Platelet glycoprotein VI.
Jung SM; Moroi M
Adv Exp Med Biol; 2008; 640():53-63. PubMed ID: 19065783
[TBL] [Abstract][Full Text] [Related]
13. Mapping the epitope of PD-L1 to the paratope of the antibody durvalumab using molecular dynamics simulation.
Tu W
Am J Transl Res; 2024; 16(1):85-97. PubMed ID: 38322578
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.
Snell DC; Schulte V; Jarvis GE; Arase K; Sakurai D; Saito T; Watson SP; Nieswandt B
Biochem J; 2002 Nov; 368(Pt 1):293-300. PubMed ID: 12117414
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the studies of platelet glycoprotein VI (GPVI): review].
Chu XX; Hou M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1040-4. PubMed ID: 17096916
[TBL] [Abstract][Full Text] [Related]
16. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
[TBL] [Abstract][Full Text] [Related]
17. Understanding antibody-antigen associations by molecular dynamics simulations: detection of important intra- and inter-molecular salt bridges.
Sinha N; Li Y; Lipschultz CA; Smith-Gill SJ
Cell Biochem Biophys; 2007; 47(3):361-75. PubMed ID: 17652781
[TBL] [Abstract][Full Text] [Related]
18. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI.
Ono K; Ueda H; Yoshizawa Y; Akazawa D; Tanimura R; Shimada I; Takahashi H
J Med Chem; 2010 Mar; 53(5):2087-93. PubMed ID: 20158191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]